Glaukos Corporation
Glaukos Corporation (United States) has no DMF, CEP or site registration linked in our records. 1 FDA enforcement record is linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Glaukos Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/glaukos-corporation
Overview
Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on developing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The company pioneered Micro-Invasive Glaucoma Surgery (MIGS) and offers a range of innovative products, including the iStent platform and the iDose TR implant.
Therapeutic areas
FDA compliance signals
1 FDA enforcement record linked to this company.
- 4832025-04-22
Investigations of discrepancies, failures
Is this Glaukos Corporation?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.